[A Case of Drug-Induced Interstitial Pneumonia after Dose-Dense AC Therapy]

Gan To Kagaku Ryoho. 2022 Dec;49(13):1642-1644.
[Article in Japanese]

Abstract

The patient is a 67-year-old female. She was diagnosed with left breast cancer cT2N1M0, Stage ⅡB, Luminal B-like, and was desided dose-dense AC therapy(ddAC)plus dose-dense paclitaxel therapy(ddPTX)as preoperative chemotherapy. After completing 4 courses of ddAC and visiting to start the first course of ddPTX, she presented with symptoms of fatigue and shortness of breath on exertion. Chest X-ray showed no abnormality and echocardiography showed decreased left ventricular wall motion, leading to a diagnosis of doxorubicin-induced cardiac dysfunction. Preoperative chemotherapy was discontinued and surgery was decided. Two weeks later, CT imaging was performed for preoperative evaluation, which showed the appearance of diffuse pale ground-glass opacity in the bilateral lung fields, and a diagnosis of drug-induced interstitial pneumonia was made. After 3 weeks of steroid treatment, the symptoms improved and the ground-glass opacity disappeared on CT imaging. We were keenly aware that interstitial pneumonia can develop with pale ground-glass opacity that is difficult to diagnose without CT imaging, and that the need for CT should always be considered.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Breast Neoplasms* / drug therapy
  • Doxorubicin / adverse effects
  • Female
  • Humans
  • Lung Diseases, Interstitial* / chemically induced
  • Lung Diseases, Interstitial* / diagnostic imaging
  • Paclitaxel / therapeutic use

Substances

  • N,N-dimethyl-N-hexadecyl-1-octadecylammonium
  • Paclitaxel
  • Doxorubicin